BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12146029)

  • 1. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids.
    Afify AM; al-Khafaji BM
    Acta Cytol; 2002; 46(4):675-8. PubMed ID: 12146029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of thyroid transcription factor-1 expression in the differential diagnosis of metastatic adenocarcinoma of serous effusion specimens prepared using the cell transfer technique.
    Jan IS; Chung PF; Weng MH; Huang MS; Lee YT; Kuo SH
    J Formos Med Assoc; 2006 Sep; 105(9):695-700. PubMed ID: 16959616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic utility of GLUT-1 expression in the cytologic evaluation of serous fluids.
    Afify A; Zhou H; Howell L; Paulino AF
    Acta Cytol; 2005; 49(6):621-6. PubMed ID: 16450901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of thyroid transcription factor-1 and CDX-2 in determining the primary site of metastatic adenocarcinomas in serous effusions.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Acta Cytol; 2010; 54(3):277-82. PubMed ID: 20518411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyroid transcription factor-1 is highly sensitive and specific in differentiating metastatic pulmonary from extrapulmonary adenocarcinoma in effusion fluid cytology specimens.
    Ng WK; Chow JC; Ng PK
    Cancer; 2002 Feb; 96(1):43-8. PubMed ID: 11836702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT
    Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of thyroid transcription factor-1 in malignant pleural effusions.
    Khoor A; Byrd-Gloster AL; Nicosia SV
    Pathol Oncol Res; 2011 Jun; 17(2):263-7. PubMed ID: 20848248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determining the primary site of metastatic adenocarcinoma in serous fluid: a cytological study].
    Fang F; Yang L; Su XL; He Q; Liu DG; Lin FR; Ma ZZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Oct; 34(10):641-5. PubMed ID: 16536276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W; Michael CW
    Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid.
    Liu L; Cohen C; Siddiqui MT
    Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies.
    Abutaily AS; Addis BJ; Roche WR
    J Clin Pathol; 2002 Sep; 55(9):662-8. PubMed ID: 12194995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].
    Zou SM; Lin DM; Lü N; Liu XY; Wen P; Liu FS
    Zhonghua Yi Xue Za Zhi; 2003 Aug; 83(15):1350-2. PubMed ID: 12930693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions.
    Jang KY; Kang MJ; Lee DG; Chung MJ
    Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The diagnostic role of claudins in serous effusions.
    Kleinberg L; Holth A; Fridman E; Schwartz I; Shih IeM; Davidson B
    Am J Clin Pathol; 2007 Jun; 127(6):928-37. PubMed ID: 17509990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin.
    Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS
    Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TTF-1 and surfactant-B as co-adjuvants in the diagnosis of lung adenocarcinoma and pleural mesothelioma.
    Bakir K; Koçer NE; Deniz H; Güldür ME
    Ann Diagn Pathol; 2004 Dec; 8(6):337-41. PubMed ID: 15614737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
    Srodon M; Westra WH
    Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid transcription factor-1 immunocytochemical staining of pleural fluid cytocentrifuge preparations for detection of small cell lung carcinoma.
    Liu J; Farhood A
    Acta Cytol; 2004; 48(5):635-40. PubMed ID: 15471255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.
    Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S
    Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study].
    Dessy E; Falleni M; Del Curto B; Braidotti P; Pietra GG
    Pathologica; 2000 Dec; 92(6):496-502. PubMed ID: 11234300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.